🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,187 results for “Takeda” Clear

  1. TAK-925

    Takeda

    Obstructive Sleep Apnea

    phase 1 small molecule completed

    1 trial

  2. TAK-931

    Takeda

    Nonhematologic Neoplasms, Advanced

    phase 1 small molecule completed

    1 trial

  3. TAK-931 PIC

    Takeda

    Neoplasms, Advanced Solid

    phase 1 small molecule completed

    1 trial

  4. TAK-935

    Takeda

    Epilepsy, Molecular Mechanisms of Pharmalogical Action, Protective Agents

    phase 1 small molecule completed

    1 trial

  5. TAK-935

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  6. TAK-935

    Takeda

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial

  7. TAK-935 Oral Tablet

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  8. TAK-935 Tablets

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  9. TAK-951

    Takeda

    Nausea and Vomitting

    phase 1 small molecule terminated

    1 trial

  10. TAK-951

    Takeda

    Healthy Volunteers

    phase 1 small molecule terminated

    1 trial

  11. TAK-951

    Takeda

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial

  12. TAK-951 Placebo

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  13. TAK-954

    Takeda

    Renal Impairment

    phase 1 small molecule completed

    1 trial

  14. TAK-954

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  15. TAK-954

    Takeda

    Hepatic Impairment

    phase 1 small molecule completed

    1 trial

  16. TAK-954

    Takeda

    Healthy Participants

    phase 1 small molecule completed

    1 trial

  17. TAK-981

    Takeda

    Head and Neck Cancer

    phase 1 small molecule completed

    1 trial

  18. TAK-988

    Takeda

    Healthy Volunteers

    phase 1 small molecule terminated

    1 trial

  19. TAK-994

    Takeda

    Healthy Participants

    phase 1 small molecule completed

    2 trials

  20. TAK-994

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  21. TAK-994 Oral Tablet

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  22. TAKC-02

    Takeda

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial

  23. TBio-6517

    Takeda

    Solid Tumor

    phase 1 mab terminated

    1 trial

  24. TDV - Low Dose

    Takeda

    Dengue Fever

    phase 1 mab completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources